CN106539022A - 一种黄精白姜复合养生含片及其制备方法 - Google Patents
一种黄精白姜复合养生含片及其制备方法 Download PDFInfo
- Publication number
- CN106539022A CN106539022A CN201610948822.1A CN201610948822A CN106539022A CN 106539022 A CN106539022 A CN 106539022A CN 201610948822 A CN201610948822 A CN 201610948822A CN 106539022 A CN106539022 A CN 106539022A
- Authority
- CN
- China
- Prior art keywords
- parts
- buccal tablet
- rhizoma polygonati
- rhizoma
- rhizoma zingiberis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 36
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 36
- 230000036541 health Effects 0.000 title claims abstract description 31
- 150000001875 compounds Chemical class 0.000 title abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 5
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 25
- 229940038481 bee pollen Drugs 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 14
- 241000234314 Zingiber Species 0.000 claims abstract description 14
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- 239000003094 microcapsule Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 6
- 238000003809 water extraction Methods 0.000 claims description 6
- 238000000748 compression moulding Methods 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 238000007908 dry granulation Methods 0.000 claims 1
- 229940116364 hard fat Drugs 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 238000005550 wet granulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 229910052725 zinc Inorganic materials 0.000 abstract description 4
- 239000011701 zinc Substances 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 3
- 230000003656 anti-hair-loss Effects 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 239000011574 phosphorus Substances 0.000 abstract description 3
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 3
- 229920001353 Dextrin Polymers 0.000 abstract description 2
- 239000004375 Dextrin Substances 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 235000019425 dextrin Nutrition 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- -1 with slow down aging Proteins 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 9
- 201000004384 Alopecia Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 231100000360 alopecia Toxicity 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 6
- 239000000686 essence Substances 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 201000009495 Hypotrichosis Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940099908 multivitamin and calcium Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种黄精白姜复合养生含片及其制备方法，所述含片由以下重量份的原料制成：白姜22‑27份、黄精32‑40份、枸杞12‑17份、葛根粉5‑13份、蜂花粉3‑7份、环糊精1‑5份、硬脂酸镁0.8‑2.5份。本发明的黄精白姜养生含片，富含蛋白质、钙、锌、磷、铁、维生素等易被吸收的营养物质，具有延缓衰老、滋阴补气、调节血糖、促进微循环、增强抵抗力等功效，适用于现代亚健康人群调理养生。此外，本发明还能滋养头发、预防脱发；本发明的黄精白姜含片，还在制备含片的过程中，采用微胶囊和冷冻干燥技术，减少了姜油的挥发，以含有粘性的蜂花粉替代大部分糊精，提高了含片的有效养生成分。
Description
技术领域
本发明属于保健食品领域，具体涉及一种黄精白姜复合养生含片及其制备方法。
背景技术
黄精，别名鸡头黄精、鸡头根、黄鸡茶，其始载于《名医别录》，将其列为上品，黄精作为一种传统的名贵中药，其味甘，性平，具有宽中益气，益肾填精，补脾润肺，强筋骨，抗衰老的作用，自古以来被视为‘药食两用；之佳品。现代药理研究发现,黄精具有多种生物活性和生理功能，黄精根茎中含有黄精多糖、黄精低聚糖、烟酸、醌类、粘液质、氨基酸,Zn、Cu和Fe等多种人体必需的微量元素；同时具有降血压，抑制高血糖以及防治动脉粥样硬化与肝脂肪浸润等药理作用；还具有明显的抗菌和抗病毒作用，可提高人体免疫力,增加体内超氧化物歧化酶的活性,延缓机体衰老等。这为开发和利用黄精资源，奠定了科学基础和理论依据。
姜，别名紫姜、生姜，性味辛、微温，归肺脾胃经，是一种开发利用价值很高的经济作物，除含有姜油酮、姜酚等生理活性物质外，还含有蛋白质、多糖、维生素和多种微量元素，集营养、调味、保健于一身，自古被医学家视为药食同源的保健品，具有祛寒、祛湿、暖胃、加速血液循环等多种保健功能。姜中含挥发油0.25％～3.0％，主要成分为姜醇、姜烯、水芹烯、莰烯、柠檬醛、芳樟醇、甲基庚烯酮、壬醛、d-龙脑等。
脱发是指头发脱落的现象，永久性脱发的掉发过程是逐渐产生的，暂时性脱发往往是由于压力大、营养不良、慢性消耗性疾病以及内分泌失调等原因造成。毛发的生长脱落，常能反应肾气的盛衰，肾气旺盛，则毛发茂密乌黑有光泽。肾气虚衰，则精血不足，导致头发缺少营养供应，则毛发稀疏易脱落或变白无光泽，对于生理性脱发只有通过合理补充营养元素，才能达到治疗的根本。
发明内容
本发明的目的是提供一种补肾健脾、滋阴补气、延缓衰老、防脱发和止脱发的黄精白姜复合养生含片。
为了实现本发明的目的，采用如下技术方案：
一种黄精白姜复合养生含片，所述含片由以下重量份的原料制成：白姜22-27份、黄精32-40份、枸杞12-17份、葛根粉5-13份、蜂花粉3-7份、环糊精1-5份、硬脂酸镁0.8-2.5份。
优选地，所述含片由以下重量份的原料制成：白姜24-26份、黄精35-38份、枸杞14-16份、葛根粉7-12份、蜂花粉4-6份、环糊精1.5-3.5份、硬脂酸镁1-1.8份。
优选地，所述含片由以下重量份的原料制成：白姜25份、黄精36份、枸杞15份、葛根粉9份、蜂花粉5份、环糊精2份、硬脂酸镁1.5份。
进一步地，一种制备黄精白姜复合养生含片的方法，包括以下步骤：
(1)称重：分别称取相应重量份的各原料；
(2)将黄精和枸杞置于提取罐中进行水提取，水的加入量为黄精和枸杞总重的1.5倍，得提取液，浓缩，得浓缩液，然后喷雾干燥，得到黄精和枸杞的混合提取物；
(3)将白姜加入到提取罐中进行水提，蒸馏，分别得到提取液和姜油，然后将提取液浓缩、喷雾干燥得白姜提取物；
(4)将环糊精加入到步骤(3)制备的姜油中，不断搅拌，温度为45-60℃，然后湿法制粒，冷冻干燥后粉碎，得姜油微胶囊粉；
(5)将蜂花粉粉碎过40目标准筛，然后冷冻干燥，备用；
(6)将白姜提取物、葛根粉和步骤(2)制备的黄精和枸杞的混合提取物混合搅拌均匀，然后将步骤(4)制备的姜油微胶囊粉加入其中，混合均匀，干燥；
(7)将步骤(6)制备的混合物中加入蜂花粉颗粒和硬脂酸镁，总混均匀，采用干法制粒，压片成型。
本发明所选择的原料，其药效和功效分别是：
白姜，性味辛、微温，归肺脾胃经，含有蛋白质、多糖、维生素和多种微量元素，集营养、调味、保健于一身，自古被医学家视为药食同源的保健品，具有祛寒、祛湿、活血、暖胃、加速血液循环等保健功能，此外还有健胃止呕、辟腥臭、消水肿之功效。
黄精：味甘、性微温。归脾、肺、胃经；具有补气养阴、健脾、润肺、益肾功能。用于治疗脾胃虚弱、体倦乏力、口干食少、肺虚燥咳、精血不足、内热消渴等症，对于糖尿病很有疗效。
枸杞：含有丰富的胡萝卜素、多种维生素和钙、铁等健康眼睛的必需营养物质，故有明目之功，俗称“明眼子”，具有抗衰老、抗疲劳、清肝明目、滋阴润肺、滋肾益精、调节血脂，提高视力和呼吸道抗病能力，美容养颜，滋润肌肤的功效。
葛根粉：是从藤本植物葛根中提取出来的一种纯天然营养佳品，味甘、辛，性凉，归肺、胃经，具有清热解毒、生津止渴、补肾健脾、益胃安神、清心明目、润肠道便及醒酒等功能。葛根淀粉内含葛根素等黄酮类化合物有效成分，具有扩张冠状动脉和脑动脉的作用，可降低血压，能显著增加缺血组织的血液供应量。葛粉中含有人体需要的十多种氨基酸和十多种微量元素，其中钙、锌、磷的含量最高，所含的富硒元素，具有一定的防癌抗癌之功效。
蜂花粉：含有蛋白质、碳水化合物、矿物质、维生素和其它活性物质，能激活巨噬细胞的吞噬活动，提高人体抗病能力；花粉中的VE、超氧化歧化酶、硒等成分能滋润营养肌肤，恢复皮肤的弹性和光洁，花粉中的肌醇可使白发变黑、脱发渐生，保持头发乌黑亮丽。
本发明的有益效果：
本发明的黄精白姜养生含片，以白姜、黄精、枸杞、葛根粉和蜂花粉为原料，使得本发明含片富含蛋白质、钙、锌、磷、铁、维生素等易被吸收的营养物质，具有延缓衰老、滋阴补气、调节血糖、促进微循环、增强抵抗力等功效，适用于现代亚健康人群调理养生。此外，本发明还能滋养头发、预防脱发；本发明的黄精白姜含片，还在制备含片的过程中，采用微胶囊和冷冻干燥技术，减少了姜油的挥发，以含有粘性的蜂花粉替代大部分糊精，提高了含片的有效养生成分。
具体实施方式
下面对本发明的实施例作详细说明，本实施例在以本发明技术方案为前提下进行实施，给出了详细的实施方式和具体的操作过程，但本发明的保护范围不限于下述的实施例。
实施例1
一种黄精白姜复合养生含片，所述含片由以下重量份的原料制成：白姜22份、黄精32份、枸杞12份、葛根粉5份、蜂花粉3份、环糊精1份、硬脂酸镁0.8份。
其中，黄精白姜复合养生含片的制备方法，包括以下步骤：
(1)称重：分别称取相应重量份的各原料；
(2)将黄精和枸杞置于提取罐中进行水提取，水的加入量为黄精和枸杞总重的1.5倍，得提取液，浓缩，得浓缩液，然后喷雾干燥，得到黄精和枸杞的混合提取物；
(3)将白姜加入到提取罐中进行水提，蒸馏，分别得到提取液和姜油，然后将提取液浓缩、喷雾干燥得白姜提取物；
(4)将环糊精加入到步骤(3)制备的姜油中，不断搅拌，温度为45-60℃，然后湿法制粒，冷冻干燥后粉碎，得姜油微胶囊粉；
(5)将蜂花粉粉碎过40目标准筛，然后冷冻干燥，备用；
(6)将白姜提取物、葛根粉和步骤(2)制备的黄精和枸杞的混合提取物混合搅拌均匀，然后将步骤(4)制备的姜油微胶囊粉加入其中，混合均匀，干燥；
(7)将步骤(6)制备的混合物中加入蜂花粉颗粒和硬脂酸镁，总混均匀，采用干法制粒，压片成型。
以下实施例与实施例1的区别仅在于，
实施例2
一种黄精白姜复合养生含片，所述含片由以下重量份的原料制成：白姜27份、黄精40份、枸杞17份、葛根粉13份、蜂花粉7份、环糊精5份、硬脂酸镁2.5份。
实施例3
一种黄精白姜复合养生含片，所述含片由以下重量份的原料制成：白姜24份、黄精35份、枸杞14份、葛根粉8份、蜂花粉5份、环糊精2份、硬脂酸镁1.3份。
实施例4
一种黄精白姜复合养生含片，所述含片由以下重量份的原料制成：白姜26份、黄精38份、枸杞15份、葛根粉11份、蜂花粉6份、环糊精3份、硬脂酸镁2份。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种黄精白姜复合养生含片，其特征在于，所述含片由以下重量份的原料制成：白姜22-27份、黄精32-40份、枸杞12-17份、葛根粉5-13份、蜂花粉3-7份、环糊精1-5份、硬脂酸镁0.8-2.5份。
2.根据权利要求1所述的一种黄精白姜复合养生含片，其特征在于，所述含片由以下重量份的原料制成：白姜24-26份、黄精35-38份、枸杞14-16份、葛根粉7-12份、蜂花粉4-6份、环糊精1.5-3.5份、硬脂酸镁1-1.8份。
3.根据权利要求1所述的一种黄精白姜复合养生含片，其特征在于，所述含片由以下重量份的原料制成：白姜25份、黄精36份、枸杞15份、葛根粉9份、蜂花粉5份、环糊精2份、硬脂酸镁1.5份。
4.一种制备如权利要求1或2或3所述的黄精白姜复合养生含片的方法，其特征在于，包括以下步骤：
(1)称重：分别称取相应重量份的各原料；
(2)将黄精和枸杞置于提取罐中进行水提取，水的加入量为黄精和枸杞总重的1.5倍，得提取液，浓缩，得浓缩液，然后喷雾干燥，得到黄精和枸杞的混合提取物；
(3)将白姜加入到提取罐中进行水提，蒸馏，分别得到提取液和姜油，然后将提取液浓缩、喷雾干燥得白姜提取物；
(4)将环糊精加入到步骤(3)制备的姜油中，不断搅拌，温度为45-60℃，然后湿法制粒，冷冻干燥后粉碎，得姜油微胶囊粉；
(5)将蜂花粉粉碎过40目标准筛，然后冷冻干燥，备用；
(6)将白姜提取物、葛根粉和步骤(2)制备的黄精和枸杞的混合提取物混合搅拌均匀，然后将步骤(4)制备的姜油微胶囊粉加入其中，混合均匀，干燥；
(7)将步骤(6)制备的混合物中加入蜂花粉颗粒和硬脂酸镁，总混均匀，采用干法制粒，压片成型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610948822.1A CN106539022A (zh) | 2016-10-26 | 2016-10-26 | 一种黄精白姜复合养生含片及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610948822.1A CN106539022A (zh) | 2016-10-26 | 2016-10-26 | 一种黄精白姜复合养生含片及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106539022A true CN106539022A (zh) | 2017-03-29 |
Family
ID=58393180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610948822.1A Pending CN106539022A (zh) | 2016-10-26 | 2016-10-26 | 一种黄精白姜复合养生含片及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106539022A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107467663A (zh) * | 2017-08-22 | 2017-12-15 | 桐城市泰安中药材种植专业合作社 | 一种黄精白姜复合养生含片及其制备方法 |
| CN108576803A (zh) * | 2018-03-28 | 2018-09-28 | 贵州坤健源生态农业发展有限公司 | 一种生食黄精片的加工方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1772151A (zh) * | 2004-11-08 | 2006-05-17 | 黄金清 | 一种治疗高脂血症的药物组合及其制备方法 |
| CN101264177A (zh) * | 2008-04-30 | 2008-09-17 | 津市市中意糖果有限公司 | 一种具有提神清咽利喉作用的压片糖果 |
| CN102908508A (zh) * | 2012-10-31 | 2013-02-06 | 李玉宾 | 一种治疗脂溢性脱发的药物组合物及其制备方法 |
| CN105011163A (zh) * | 2015-07-27 | 2015-11-04 | 池州市九华山黄精研究所 | 黄精白姜保健品及其制备方法 |
-
2016
- 2016-10-26 CN CN201610948822.1A patent/CN106539022A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1772151A (zh) * | 2004-11-08 | 2006-05-17 | 黄金清 | 一种治疗高脂血症的药物组合及其制备方法 |
| CN101264177A (zh) * | 2008-04-30 | 2008-09-17 | 津市市中意糖果有限公司 | 一种具有提神清咽利喉作用的压片糖果 |
| CN102908508A (zh) * | 2012-10-31 | 2013-02-06 | 李玉宾 | 一种治疗脂溢性脱发的药物组合物及其制备方法 |
| CN105011163A (zh) * | 2015-07-27 | 2015-11-04 | 池州市九华山黄精研究所 | 黄精白姜保健品及其制备方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107467663A (zh) * | 2017-08-22 | 2017-12-15 | 桐城市泰安中药材种植专业合作社 | 一种黄精白姜复合养生含片及其制备方法 |
| CN108576803A (zh) * | 2018-03-28 | 2018-09-28 | 贵州坤健源生态农业发展有限公司 | 一种生食黄精片的加工方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101999647B (zh) | 功能含化阿胶系列产品及其制备方法 | |
| CN1170588A (zh) | 一种纯天然植物人体生命核能营养基质 | |
| CN1939475A (zh) | 枸杞葛根胶囊及其制备工艺 | |
| CN105494844A (zh) | 一种枸杞压片糖果生产方法 | |
| CN104232446A (zh) | 一种墨米滋补酒的制备方法 | |
| KR20120056425A (ko) | 탈모에 효과적인 건강보조식품 및 그 제조방법 | |
| CN102823654A (zh) | 系列中药保健奶片及其制备方法 | |
| CN106539022A (zh) | 一种黄精白姜复合养生含片及其制备方法 | |
| CN105831351A (zh) | 一种清肝理气的花草茶及其制备方法 | |
| CN103734767B (zh) | 一种保健食品 | |
| CN104312875A (zh) | 一种小米滋补酒的制备方法 | |
| KR101391466B1 (ko) | 한약재를 이용한 사료첨가제 및 그 제조방법 | |
| CN105495603A (zh) | 一种高丽红参山楂细胞破壁超微粉的制备方法 | |
| CN104893919A (zh) | 一种玉米滋补酒的制备方法 | |
| CN101804018A (zh) | 一种具有祛黄褐斑功能的中药面膜粉及其制备方法 | |
| CN108419977A (zh) | 一种解酒护肝的水飞蓟油固态饮料及其制备方法 | |
| CN107028182A (zh) | 一种抗衰老组合物及制备方法 | |
| CN103054073B (zh) | 一种养颜鱼鳞冻及其制备方法 | |
| CN106036906A (zh) | 一种养血安神富硒葛根龟苓膏及其制备方法 | |
| CN105533073A (zh) | 具有补气血、美容养颜功效的红枣袋泡茶及其制备工艺 | |
| CN109511790A (zh) | 一种肉羊中草药舔砖及其制备方法 | |
| CN103933409A (zh) | 复方补骨脂黑发软胶丸 | |
| CN106261586A (zh) | 一种改善亚健康的绿色糕点及其制备方法 | |
| CN106376819A (zh) | 一种葛根红枣冲剂及其制备方法 | |
| KR101129663B1 (ko) | 기능성 재료가 가미된 전두부의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170329 |